N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide Grant US-RE49445-E1 United States of America 07 Mar 2023
Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices Grant US-11033490-B2 United States of America 15 Jun 2021
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide Grant US-RE48285-E1 United States of America 27 Oct 2020
Methods of predicting resistance to JAK inhibitor therapy Grant US-10155987-B2 United States of America 18 Dec 2018